tenofovir has been researched along with Complications, Infectious Pregnancy in 153 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.65) | 18.2507 |
| 2000's | 8 (5.23) | 29.6817 |
| 2010's | 104 (67.97) | 24.3611 |
| 2020's | 40 (26.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Dumond, JB; Fiscus, SA; Horton, AL; Kashuba, AD; Patterson, KB; Rezk, NL; Tappouni, HL; Tien, HC; Vourvahis, M; Yeh, RF | 1 |
| Ahmed, K; Bekker, LG; Brumskine, W; Chersich, MF; Delany-Moretlwe, S; Doncel, GF; Gray, G; Kotze, P; Lombard, C; Mabude, Z; Mogodiri, T; Munthali, RJ; Myer, L; Naidoo, I; Nchabeleng, M; Nkala, B; Palanee-Phillips, T; Panchia, R; Rees, H; Sebe, M | 1 |
| Chen, L; Chen, X; Dai, E; Li, C; Li, S; Lv, X; Zhao, Z; Zhu, B | 1 |
| Achalapong, J; Bunpo, P; Cressey, R; Jourdain, G; Kanjanavikai, P; Liegeon, G; Ngo-Giang-Huong, N; Patamasingh Na Ayudhaya, O; Prommas, S; Sabsanong, P; Salvadori, N; Siriwachirachai, T; Yves Mary, J | 1 |
| Barr, E; Best, BM; Brooks, KM; Browning, R; Capparelli, EV; Chakhtoura, N; Deville, JG; Febo, IL; George, K; Knowles, K; Mirochnick, M; Paul, ME; Pinilla, M; Rungruengthanakit, K; Shapiro, DE; Stek, AM | 1 |
| Anothaisintawee, T; Attia, J; Chaikledkaew, U; Chaiyakunapruk, N; McKay, GJ; Nguyen, HT; Phung, TL; Sobhonslidsuk, A; Talungchit, P; Thakkinstian, A; Thavorncharoensap, M | 1 |
| Barkema, HW; Coffin, CS; Samadi Kochaksaraei, G; Seow, CH; Shaheen, AA | 1 |
| Chang, KC; Chang, MH; Chen, HL; Cheng, SW; Chiang, CL; Hsu, HY; Hu, JJ; Lai, MW; Lee, CN; Liu, CJ; Mu, SC; Ni, YH; Wen, WH; Wu, JF | 1 |
| Ran, R; Wang, M; Zhang, H; Zhu, Y | 1 |
| Cai, H; Gao, X; Li, Z; Xie, B; Yi, N; Yi, W | 1 |
| Bi, X; Deng, W; Jiang, T; Li, M; Lin, Y; Lu, Y; Sun, F; Xie, Y; Yang, L; Yi, W; Zhang, L | 1 |
| Gartlehner, G; Harlfinger, J; Nußbaumer-Streit, B | 1 |
| Adekanle, O; Adeyemi, A; Anyabolu, C; Awowole, I; Ijadunola, M; Ijarotimi, O; Kuti, O; Makinde, O; Ndububa, D | 1 |
| Jiang, X; Jiang, Y; Jin, J; Li, S; Lin, N; Ma, Z; Shi, J | 1 |
| Janekrongtham, C; Jantarapakde, J; Lertpiriyasuwat, C; Pan-Ngum, W; Poovorawan, K; Punsuwan, N; Tangkijvanich, P; Thitichai, P | 1 |
| Chandiwana, P; Duri, K; Gumbo, FZ; Marere, T; Mataramvura, H; Mazengera, LR; Mazhandu, AJ; Munjoma, PT | 1 |
| Bührer, C; Feiterna-Sperling, C; Henrich, W; Krüger, R; Rancourt, RC; Seidel, V; Weizsäcker, K | 1 |
| Chadwick, EG; Correia, KF; Crowell, CS; DiPerna, A; Hazra, R; Seage, GR; Smith, R; Van Dyke, RB; Williams, PL; Yildirim, C | 1 |
| Chi, BH; Fairlie, L; Farhad, M; Fenton, T; Fowler, MG; Moodley, D; Naik, S; Nakabiito, C; Stringer, JSA; Venkatesh, KK | 1 |
| Khamrin, P; Kumthip, K; Malasao, R; Maneekarn, N; Sirilert, S; Tongsong, T | 1 |
| Bak, H; Byun, KS; Chang, SW; Hyun, MH; Jung, YK; Kim, JH; Kim, S; Lee, CU; Lee, HS; Lee, MJ; Lee, YS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ | 1 |
| Cai, H; Duan, X; Fu, D; Gao, X; Hu, Y; Kang, K; Liu, M; Yi, W; Zhou, M | 1 |
| Aldrovandi, G; Baeten, JM; Baggaley, R; Bekker, LG; Celum, C; Chi, BH; Coates, TJ; Haberer, JE; Heffron, R; John-Stewart, G; Joseph Davey, DL; Kinuthia, J; Matthews, LT; McIntyre, J; Mofenson, LM; Moodley, D; Mugo, N; Mujugira, A; Myer, L; Pintye, J; Shoptaw, S; Stranix-Chibanda, L | 1 |
| He, D; Jiang, H; Jin, J; Li, S; Lin, N; Ma, Z; Wang, Y; Zhou, H | 1 |
| Chen, K; Deng, H; Gao, H; Jiao, Q; Lei, Y; Li, H; Liang, S; Lin, L; Liu, H; Shi, Y; Xu, M; Zhuo, L | 1 |
| Brooks, KM; Dooley, KE; Eke, AC; Gebreyohannes, RD; Mirochnick, M; Sheffield, JS | 1 |
| Chen, G; Cui, F; Liang, P; Liang, X; Wang, F; Yin, J; Zhuang, G | 1 |
| Pan, CQ; Wen, WH; Wong, GL | 1 |
| Gandhi, M; Huo, Y; Kacanek, D; Kuncze, K; Okochi, H; Pintye, J; Zhang, K | 1 |
| Boucheron, P; Bulterys, M; Chou, R; Funk, AL; Lu, Y; Shimakawa, Y; van Holten, J; Yoshida, K; Zhao, T | 1 |
| Cao, L; Chen, B; Chen, R; Ding, Y; Fan, J; Gan, W; Huang, Y; Lin, C; Liu, Y; Pan, CQ; Sheng, Q; Wang, S; Wang, Y; Zhu, L | 1 |
| Angkurawaranon, C; Bierhoff, M; Ehrhardt, S; McGready, R; Nosten, F; Pimanpanarak, M; Rijken, MJ; Thio, CL; van Vugt, M; Yotyingaphiram, W | 1 |
| Angkurawaranon, C; Bierhoff, M; Carrara, V; Ehrhardt, S; Guo, N; Jia, Y; Jittamala, P; Ling, C; McGready, R; Nelson, KE; Nosten, F; Rijken, M; Thio, CL; Tongprasert, F; van Vugt, M; Watthanaworawit, W | 1 |
| Flomo, KT; Ma, Y; Yang, Q; Yang, Y; Zhong, Z | 1 |
| Bukkems, VE; Burger, DM; Colbers, AP; Cressey, TR; Jourdain, G; Smolders, EJ | 1 |
| Aspinall, AI; Barkema, HW; Borman, MA; Burak, KW; Castillo, E; Coffin, CS; Congly, SE; Israelson, H; Lee, SS; Martin, SR; Pinto, J; Sadler, MD; Samadi Kochaksaraei, G; Seow, CH; Shaheen, AA; Stinton, LM; Swain, MG; Williams, S | 1 |
| Chen, ZM; Cui, GL; Ji, F; Li, GM; Li, J; Li, W; Li, ZQ; Liang, HX; Liu, YM; Lv, J; Pan, YJ; Sun, CY; Wang, FS; Xu, JH; Yu, ZJ; Zeng, QL; Zhang, DW; Zhang, GF | 1 |
| Angkurawaranon, C; Bierhoff, M; Devine, A; Kobphan, P; McGready, R; Nosten, FN; Rijken, MJ; Sriprawa, K; van Vugt, M | 1 |
| Chan, P; Cui, F; Fuzhen, W; Guomin, Z; Hallett, TB; Hui, Z; Nayagam, S; Ning, M; Thursz, M; Xiaojin, S; Zundong, Y | 1 |
| Amico, KR; Brummel, SS; Cassim, H; Chakhtoura, N; Chinula, L; Coletti, A; Currier, J; Fairlie, L; Frenkel, LM; Hanley, S; Hoffman, RM; Holmes, LB; Jean-Philippe, P; João, E; Johnston, B; Korutaro, V; Krotje, C; Lockman, S; Masheto, G; McCarthy, K; Mmbaga, BT; Momper, JD; Moyo, S; Purdue, L; Rooney, JF; Sax, PE; Shapiro, RL; Stranix-Chibanda, L; Stringer, JS; Thoofer, NK; Ziemba, L | 1 |
| Bateman, BT; Fischer, M; Hernández-Díaz, S; Huybrechts, KF; Mogun, H; Straub, L; Zhu, Y | 1 |
| Li, EM; Li, JQ; Lin, CS; Mei, YY; Mo, ZS; Xiao, LX; Xu, Z | 1 |
| Chamroonkul, N; Piratvisuth, T | 1 |
| Byun, KS; Hyun, MH; Je, JH; Kim, JH; Lee, YS; Yeon, JE; Yoo, YJ | 1 |
| Aberra, H; Berhe, N; Desalegn, H; Gundersen, SG; Johannessen, A; Medhin, G; Stene-Johansen, K | 1 |
| Ahir, BK; Li, LQ; Wu, GB; Zhang, CY; Zhong, JH | 1 |
| Agarwal, A; Alexander, PE; Chang, Y; Foroutan, F; Guyatt, GH; Hepworth, E; Lee, Y; Lesi, O; Mah Ming, J; Merglen, A; Mir, H; Mirza, R; Siemieniuk, RA; Zeraatkar, D; Zhang, Y | 1 |
| Bonito, A; Bonora, S; Calcagno, A; Casari, S; Castelli, F; D'Avolio, A; Di Perri, G; Domenighini, E; Focà, E; Quiros Roldan, E; Simiele, M; Trentini, L | 1 |
| Burman, BE; Jhaveri, MA; Kowdley, KV | 1 |
| Jhaveri, R; Meshnick, SR; Parr, JB; Wilson, P | 1 |
| Chetty, T; Coutsoudis, A; Thorne, C | 1 |
| Achalapong, J; Bowonwatanuwong, C; Buranabanjasatean, S; Chakhtoura, N; Chotivanich, N; Chung, RT; Cressey, TR; Decker, L; Harrison, L; Jourdain, G; Kanjanavikai, P; Khamduang, W; Klinbuayaem, V; Liampongsabuddhi, P; Limtrakul, A; Matanasarawut, W; Murphy, TV; Na Ayudhaya, OP; Nelson, NP; Ngo-Giang-Huong, N; Pol, S; Prommas, S; Puernngooluerm, P; Puthanakit, T; Putiyanun, C; Sabsanong, P; Salvadori, N; Sangsawang, S; Siberry, GK; Sirirungsi, W; Siriwachirachai, T; Suriyachai, P; Thanprasertsuk, S; Thongsawat, S; Tierney, C; Varadisai, S; Watts, DH; Yuthavisuthi, P | 1 |
| Diseko, M; Essex, M; Jacobson, DL; Lockman, S; Makhema, J; Mayondi, G; Mmalane, M; Petlo, C; Rough, K; Shapiro, RL; Zash, R | 1 |
| Barr, E; Chadwick, EG; Currier, JS; Hernandez-Diaz, S; Hoffman, RM; Huo, Y; Patel, K; Rough, K; Seage, GR; Shapiro, DE; Williams, PL | 1 |
| Chan, P; Cui, F; Woodring, J; Xu, F | 1 |
| Harrison, L; Jourdain, G; Ngo-Giang-Huong, N | 1 |
| Feld, JJ; Lok, ASF; Terrault, NA | 1 |
| Gerlich, W; Glebe, D | 1 |
| Cheung, KW; Ng, EHY; Seto, MTY | 1 |
| Asci, Z; Demir, LS; Demir, NA; Kolgelier, S; Ozcimen, S; Sumer, S; Ural, O | 1 |
| Bulterys, M; Chen, L; Fan, B; Kourtis, AP; Liu, W; Shepard, C; Shepherd, JA; Wang, A; Wang, L; Wiener, J | 1 |
| Jia, L; Li, W; Tang, H; Wu, X; Zhao, X | 1 |
| Cui, F; Ding, Y; Dou, X; Duan, Z; Han, G; Hou, J; Jia, J; Li, J; Li, Z; Liu, Z; Mao, Q; Wei, L; Xie, Q; Yang, X; Zhang, H; Zhuang, H | 1 |
| Davies, N; Heffron, R | 1 |
| McCormick, CA; McCormick, PA | 1 |
| Duff, P; Sylvester-Armstrong, KR | 1 |
| Bulterys, M; Cressey, TR; Decker, L; Fan, B; Harrison, L; Jourdain, G; Khamduang, W; Kourtis, AP; Luvira, A; Ngo-Giang-Huong, N; Phanomcheong, S; Puangsombat, A; Putiyanun, C; Salvadori, N; Shepherd, JA; Siberry, GK; Srirompotong, U; Suwannarat, A; Teeyasoontranon, W; Tierney, C | 1 |
| Li, H; Zeng, J; Zheng, C | 1 |
| Belle, SH; Bzowej, NH; Chung, R; Khalili, M; Li, R; Smith, CI; Terrault, N; Tran, TT; Tsai, N | 1 |
| Andersson, M; Barnes, EJ; Burn, EAO; Goedhals, D; Matthews, PC; Mokaya, J; Pinedo-Villanueva, R; Tamandjou, CR | 1 |
| Baeten, JM; Bangsberg, DR; Haberer, JE; Hendrix, C; Jaggernath, M; Kriel, Y; Matthews, LT; O'Neil, K; Psaros, C; Smit, JA; Smith, PM; Ware, NC; Wirth, K | 1 |
| Hu, X; Wang, L; Xu, F | 1 |
| Chagomerana, MB; DiPrete, BL; Harrington, BJ; Hosseinipour, MC; Jumbe, AN; Limarzi, L; Ngongondo, M; Wallie, SD | 1 |
| Horváth, G | 1 |
| Emel, L; Eshleman, SH; Fowler, MG; George, K; Herron, C; Hudelson, SE; Joao, E; Kearney, B; Kreitchmann, R; Kumwenda, N; Mirochnick, M; Mofenson, L; Nielsen-Saines, K; Parsons, T; Pinto, J; Richardson, P; Santos, B; Sato, P; Taha, T | 1 |
| Bulterys, M; Ellington, S; Kourtis, AP; Legardy-Williams, J; Wang, L | 1 |
| Bekker, LG; Kamkuemah, M; Kaplan, R; Myer, L | 1 |
| Huo, Y; Livingston, EG; Patel, K; Ransom, CE; Scott, GB; Siberry, GK; Watts, HD; Williams, P | 1 |
| Ay, M; Ayaz, C; Barcin, T; Celen, MK; Dal, MS; Dal, T; Gulsun, S; Kalkanli, S; Kaya, S; Mert, D; Yildirim, N | 1 |
| Chatterjee, U; Davison, S; Glass, A; Greenup, AJ; Holdaway, S; Jackson, K; Levy, MT; Locarnini, SA; Nguyen, V; Samarasinghe, D; Strasser, SI; Tan, PK | 1 |
| Chimbwandira, FM; Chirwa, Z; Crampin, AC; Dasgupta, AN; Glynn, JR; Jahn, A; Katundu, C; Kayange, M; Koole, O; Price, AJ; Saul, JL; Zaba, B | 1 |
| Chatterjee, U; Davison, S; Glass, A; Greenup, AJ; Holdaway, S; Jackson, K; Levy, MT; Locarnini, SA; Nguyen, V; Samarasinghe, D; Tan, PK | 1 |
| Gerlich, WH | 1 |
| Baeten, JM; Bangsberg, DR; Celum, C; Cohen, CR; Heffron, R; Hendrix, CW; Matthews, LT; Mugo, NR | 1 |
| André-Schmutz, I; Azria, E; Blanche, S; Cavazzana, M; Cordier, AG; Cuccuini, W; Lechenadec, J; Luce, S; Mandelbrot, L; Soheili, TS; Soulier, J; Vivanti, A | 1 |
| Cai, HD; Cao, YJ; Hu, YH; Liu, M; Yi, W | 1 |
| Chan, KA; Chang, CH; Chang, MH; Chen, DS; Chen, HL; Chen, SM; Hsu, JJ; Hu, JJ; Lai, MW; Lee, CL; Lee, CN; Lin, HH; Lin, HM; Mu, SC; Ni, YH; Shyu, MK; Tsai, MS; Zhao, LL | 1 |
| Gordon, M; Moodley, P; Naidoo, A; Parboosing, R; Paredes, R; Samuel, R; Singh, L | 1 |
| Best, BM; Burchett, S; Byroads, M; Capparelli, EV; Fletcher, CV; Hawkins, E; Hu, C; Li, H; Mirochnick, M; Smith, E; Stek, A; Wang, J; Watts, DH | 1 |
| Hazra, R; Himes, SK; Huestis, MA; Jacobson, DL; Kacanek, D; Rich, KC; Siberry, GK; Tassiopoulos, K; Van Dyke, RB; Wu, JW | 1 |
| Barr, E; Butler, L; Davtyan, M; DiMeglio, LA; Hazra, R; Jacobson, DL; Kalkwarf, HJ; Knapp, KM; Miller, TL; Mofenson, LM; Rich, KC; Seage, GR; Siberry, GK; Van Dyke, RB; Wheeler, JJ; Wu, JW; Yogev, R | 1 |
| El Agheb, MO; Grange, JD | 1 |
| Castillo, E; Coffin, CS; Lee, SS; Martin, SR; Myers, RP; Oshiomogho, JI; Osman, M; Samadi Kochaksaraei, G; Scott, AN; Simmonds, K | 1 |
| Cao, F; Chen, T; He, Y; Jin, L; Liu, J; Qi, C; Wang, J; Yan, T; Yang, Y; Zhang, S; Zhao, Y | 1 |
| Baeten, JM; Bii, DK; Bukusi, EA; Bulya, N; Campbell, JD; Celum, C; Egessa, JJ; John-Stewart, G; Kusemererwa, S; Morrison, S; Mubezi, S; Mugume, F; Wangisi, J | 1 |
| Castillo, E; Coffin, CS; Gao, S; Lee, SS; Martin, SR; Osiowy, C; Simmonds, K; van Marle, G; Virine, B; Wang, T | 1 |
| Andreotti, M; Floridia, M; Galluzzo, CM; Giuliano, M; Jere, H; Liotta, G; Luhanga, R; Mancinelli, S; Marazzi, MC; Marchei, E; Mwenda, R; Palombi, L; Pichini, S; Pirillo, MF; Sagno, JB; Vella, S | 1 |
| Andreotti, M; Buonomo, E; Floridia, M; Giuliano, M; Jere, H; Liotta, G; Mancinelli, S; Marazzi, MC; Palombi, L; Sagno, JB; Scarcella, P; Vella, S | 1 |
| John-Stewart, G; Katana, A; Kinuthia, J; Langat, A; McGrath, CJ; Nganga, L; Odeny, B; Pintye, J; Singa, B | 1 |
| Heffron, R; Matthews, LT; Mugo, N; Pintye, J; Weber, S | 1 |
| Abrams, EJ; Jao, J; Myer, L; Petro, G; Phillips, T; Zerbe, A | 1 |
| Dai, E; Duan, Z; Han, G; Jiang, H; Pan, CQ; Wang, Y; Zhang, H; Zhang, S; Zhao, W; Zhu, B; Zou, H | 1 |
| Gordon, M; Julian, MN; Moodley, P; Naidoo, A; Parboosing, R; Paredes, R; Samuel, R; Singh, L | 1 |
| Bunders, MJ; Cohen, S; Denneman, L; Godfried, MH; Kuijpers, TW; Nellen, JF; Pajkrt, D; Scherpbier, HJ; Smit, C; van de Plas, A; van Leeuwen, E; Weijsenfeld, AM | 2 |
| Achalapong, J; Bowonwatanuwong, C; Chotivanich, N; Chung, RT; Cressey, TR; Decker, L; Harrison, L; Hongsiriwon, S; Hua, L; Jourdain, G; Khamduang, W; Klinbuayaem, V; Murphy, TV; Ngo-Giang-Huong, N; Pol, S; Puthanakit, T; Salvadori, N; Siberry, GK; Sirirungsi, W; Thongsawat, S; Tierney, C; Traisathit, P; Watts, DH | 1 |
| Amici, R; Andreotti, M; Floridia, M; Galluzzo, CM; Giuliano, M; Jere, H; Liotta, G; Mancinelli, S; Marazzi, MC; Palombi, L; Sagno, JB; Vella, S | 1 |
| Mathew, JL | 1 |
| Gupta, B | 1 |
| Chawla, D | 1 |
| Boechat, MI; Emel, L; George, K; Joao, E; Kreitchmann, R; Kumwenda, N; Mirochnick, M; Mofenson, L; Nielsen-Saines, K; Osorio, LE; Pinto, J; Santos, B; Sato, P; Swenson, M | 1 |
| Bénifla, JL; Berçot, B; Bergmann, JF; Chopin, D; Delcey, V; Evans, J; Lopes, A; Maylin, S; Sellier, PO; Simon, F; Simoneau, G | 1 |
| Abrams, EJ; Brittain, K; Jao, J; M le Roux, S; Myer, L; Olatunbosun, S; Phillips, TK; Ronan, A; Zerbe, A | 1 |
| Harrison, M; Matjila, M; Riemer, L; Tooke, L | 1 |
| Abrams, EJ; Jao, J; le Roux, SM; Malaba, T; Myer, L | 1 |
| Masoumy, EP; Stansfield, BK | 1 |
| Anderson, JR; Doherty, MC; Essajee, S; Ford, N; Kanters, S; Mills, EJ; Mofenson, LM; Nachega, JB; Renaud, F; Uthman, OA | 1 |
| Cantrell, RA; Chi, BH; Chintu, N; Kankasa, C; Kruse, G; Mbewe, F; Sinkala, M; Smith, PJ; Stringer, EM; Stringer, JS | 1 |
| Abel, K; Bischofberger, N; Brignolo, LL; Cihlar, T; Durand-Gasselin, L; Jerome, C; Kearney, BP; Marthas, ML; Moore, J; Ray, AS; Reiser, H; Spinner, A; Van Rompay, KK | 1 |
| Amani-Bosse, C; Arrivé, E; Blanche, S; Dabis, F; Ekouévi, DK; Gray, G; Hirt, D; Kone, M; Leang, SK; McIntyre, J; Nerrienet, E; Rey, E; Tréluyer, JM; Urien, S | 1 |
| Arrivé, E; Avit, D; Blanche, S; Coffié, P; Dabis, F; Ekouévi, DK; Hirt, D; Lalsab, S; Leang, SK; McIntyre, J; Nerrienet, E; Rey, E; Tréluyer, JM; Urien, S | 1 |
| Foster, C; Gibb, DM; Lyall, H; Olmscheid, B; Pearce, G; Zhang, S | 1 |
| Aldrovandi, GM; Cantrell, RA; Chi, BH; Chintu, N; Ellis, GM; Frenkel, LM; Mbewe, F; Nakamura, K; Sinkala, M; Stringer, EM; Stringer, JS; Warrier, R | 1 |
| Anzidei, G; Baroncelli, S; Cauda, R; Cusato, M; De Luca, A; Fantoni, M; Floridia, M; Pinnetti, C; Regazzi, M; Tamburrini, E; Tozzi, V; Villani, P | 1 |
| Baleta, A | 1 |
| Murphy, B; Romanelli, F | 1 |
| Alston-Smith, B; Asmelash, A; Atwine, D; Chipato, T; Conradie, F; Currier, JS; Eshleman, S; Hakim, J; Hogg, E; Hosseinipour, MC; Hughes, MD; Kanyama, C; Lockman, S; McIntyre, J; Mellors, JW; Mngqibisa, R; Mohapi, L; Purcelle-Smith, E; Rahim, S; Rooney, J; Salata, RA; Sawe, F; Schooley, RT; Shaffer, D; Siika, A; Stringer, E; Walawander, A; Wools-Kaloustian, K; Zheng, Y | 1 |
| Bygrave, H; Ford, N; Goemaere, E; Hilderbrand, K; Jouquet, G; Kranzer, K; Makakole, L; Triviño, L; van Cutsem, G; Vlahakis, N | 1 |
| Basar, M; Best, BM; Burchett, SK; Capparelli, EV; Hawkins, E; Hu, C; Mirochnick, M; Read, JS; Rossi, SS; Smith, E; Stek, AM | 1 |
| Arrivé, E; Blanche, S; Dabis, F; Ekouévi, DK; Gray, G; Hirt, D; Kone, M; Kruy, LS; Nerrienet, E; Nyati, M; Pruvost, A; Tréluyer, JM; Urien, S | 1 |
| Amani-Bosse, C; Arrivé, E; Avit, D; Blanche, S; Dabis, F; Ek, ML; Ekouévi, DK; Hirt, D; Legote, S; McIntyre, J; Nyati, M; Pruvost, A; Say, L; Tréluyer, JM; Urien, S | 1 |
| Donnelly, J | 1 |
| Giles, M; Sasadeusz, J; Visvanathan, K | 1 |
| Bardeguez, A; Cotter, A; Fiscus, SA; Flynn, PM; Heckman, B; Huang, S; Jean-Philippe, P; Kearney, B; Mirochnick, M; Mofenson, LM; Purswani, M; Robbins, B; Rodman, J; Rooney, JF; Shapiro, DE; Thorpe, E; Van Rompay, KK; Watts, DH | 1 |
| Benaboud, S; Bouazza, N; Chappuy, H; Firtion, G; Foissac, F; Hirt, D; Launay, O; Pannier, E; Rey, E; Tréluyer, JM; Urien, S | 1 |
| Back, DJ; Else, LJ; Khoo, SH; Taylor, S | 1 |
| DiMeglio, LA; Griner, R; Hazra, R; Jacobson, DL; Kacanek, D; Mendez, H; Miller, T; Mofenson, LM; Rich, KC; Seage, GR; Siberry, GK; Tassiopoulos, K; Watts, DH; Williams, PL | 1 |
| Friend, DR | 1 |
| Lee, WM; Tujios, SR | 1 |
| Bulterys, M; Kuhn, L | 1 |
| Chidziva, E; Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kizito, H; Kyomugisha, H; Munderi, P; Musoke, P; Nalumenya, R; Nathoo, K; Russell, EC; Spyer, M; Tumukunde, D; Walker, AS; Zalwango, E | 1 |
| Akinkuotu, A; Chasela, C; Hosseinipour, MC; Jamieson, DJ; Johnson, DC; King, CC; Kourtis, AP; Maliwichi, M; Moses, A; Mwafongo, A; van der Horst, C | 1 |
| Firnhaber, C; Maskew, M; Sanne, I; Westreich, D | 1 |
| Gatanaga, H; Gomibuchi, H; Hosokawa, S; Kikuchi, Y; Kinai, E; Oka, S | 1 |
| Baak, BC; Bakker, CM; Beuers, UH; Brouwer, JT; Buster, EH; Drenth, JP; Honkoop, P; Janssen, HL; Kerbert-Dreteler, MJ; Koek, GH; Tan, AC; van der Spek, BW; van Erpecum, KJ; van Hoek, B; van Nieuwkerk, KM; van Soest, H; Vrolijk, JM | 1 |
| Burger, DM; Colbers, AP; Giaquinto, C; Gingelmaier, A; Hawkins, DA; Ivanovic, J; Kabeya, K; Moltó, J; Rockstroh, JK; Sadiq, ST; Taylor, GP; Weizsäcker, K; Wyen, C | 1 |
| Coffin, CS; Fung, SK; Ma, MM | 1 |
| Best, BM; Burchett, SK; Byroads, M; Caparelli, E; Cressey, TR; Hawkins, E; Kreitchmann, R; Mirochnick, M; Rossi, S; Shapiro, DE; Smith, E; Stek, A; Wang, J; Watts, DH | 1 |
| Bedini, A; Borghi, V; Esposito, R; Mussini, C; Prati, F; Sabbatini, F | 1 |
| Bischofberger, N; Cundy, K; Marthas, ML; Shaw, JP; Tarantal, AF | 1 |
27 review(s) available for tenofovir and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Comparative efficacy and safety of pharmacologic interventions to prevent mother-to-child transmission of hepatitis B virus: a systematic review and network meta-analysis.
Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Infant; Infectious Disease Transmission, Vertical; Network Meta-Analysis; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load | 2022 |
Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load | 2022 |
Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis.
Topics: Antiviral Agents; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome; Viral Load | 2021 |
Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
Topics: Adult; Anti-HIV Agents; Breast Feeding; Female; HIV Infections; HIV-1; Humans; Postnatal Care; Pre-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Young Adult | 2020 |
Tenofovir alafenamide use in pregnant and lactating women living with HIV.
Topics: Adenine; Alanine; Anti-HIV Agents; Female; HIV Infections; Humans; Lactation; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Tenofovir | 2020 |
Hepatitis B-management of acute infection and active inflammation in pregnancy-a hepatologist's perspective.
Topics: Adult; Antiviral Agents; Child; DNA, Viral; Female; Gastroenterologists; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Inflammation; Male; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Tenofovir | 2020 |
Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
Topics: Adult; Antiviral Agents; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Tenofovir | 2021 |
Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis.
Topics: Antiviral Agents; Confidence Intervals; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Observational Studies as Topic; Pregnancy; Pregnancy Complications, Infectious; Publication Bias; Randomized Controlled Trials as Topic; Tenofovir | 2020 |
Safety of Tenofovir Disoproxil Fumarate for Pregnant Women Facing the Coronavirus Disease 2019 Pandemic.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Female; HIV Infections; Humans; Pandemics; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnant Women; Reverse Transcriptase Inhibitors; SARS-CoV-2; Tenofovir | 2021 |
Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.
Topics: Antiviral Agents; Endemic Diseases; Female; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunization; Immunoglobulins; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Tenofovir; Thymidine; Viral Load | 2017 |
Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus.
Topics: Combined Modality Therapy; Female; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Treatment Outcome; Viral Load | 2017 |
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.
Topics: Adult; Anti-Retroviral Agents; Drug Combinations; Emtricitabine; Female; Hepatitis B; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ritonavir; Tenofovir; Young Adult; Zidovudine | 2017 |
Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies from other countries.
Topics: Alanine Transaminase; Antiviral Agents; Creatine Kinase; Creatinine; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load | 2018 |
Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus.
Topics: Algorithms; Antiviral Agents; Breast Feeding; Female; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Immunologic Factors; Infant, Newborn; Infectious Disease Transmission, Vertical; Mass Screening; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Vaccination; Viral Load | 2019 |
Global and national guidance for the use of pre-exposure prophylaxis during peri-conception, pregnancy and breastfeeding.
Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Drug Therapy, Combination; Female; Global Health; HIV Infections; Humans; Middle Aged; Practice Guidelines as Topic; Pre-Exposure Prophylaxis; Preconception Care; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2018 |
Evidence for Use of Tenofovir in Pregnancy to Prevent Perinatal Transmission of Hepatitis B Infection.
Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viremia | 2019 |
Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage.
Topics: Animals; Anti-HIV Agents; Antiviral Agents; Female; Hepatitis B; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Milk, Human; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2019 |
[Interdisciplinary aspects of and new drugs for chronic hepatitis B].
Topics: Adenine; Antiviral Agents; Comorbidity; Drug Interactions; Drug Therapy, Combination; Female; Gastroenterology; Guanine; Hematology; Hepatitis B, Chronic; Humans; Hungary; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Interdisciplinary Communication; Interferons; Lamivudine; Medical Oncology; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Rheumatology; Tenofovir | 2013 |
Safety of tenofovir during pregnancy for the mother and fetus: a systematic review.
Topics: Adenine; Animals; Female; Fetal Development; HIV Infections; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2013 |
PrEP as Peri-conception HIV Prevention for Women and Men.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Kenya; Male; Medication Adherence; Pre-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Randomized Controlled Trials as Topic; Tenofovir; Uganda | 2016 |
Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
Topics: Anti-HIV Agents; Birth Weight; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Patient Safety; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Tenofovir | 2017 |
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
Topics: Adenine; Adult; Africa South of the Sahara; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Child; Child, Preschool; Congenital Abnormalities; Disease Models, Animal; Drug Resistance, Viral; Female; Health Services Accessibility; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Macaca; Mitochondria; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine | 2009 |
Systemic preexposure prophylaxis for human immunodeficiency virus infection.
Topics: Adenine; Animals; Anti-HIV Agents; Antiviral Agents; Deoxycytidine; Emtricitabine; Female; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Occupational Exposure; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Risk Factors; Risk-Taking; Tenofovir | 2010 |
Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
Topics: Adenine; Antiviral Agents; Breast Feeding; Female; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2011 |
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).
Topics: Adenine; Adult; Amniotic Fluid; Anti-HIV Agents; Cyclohexanes; Enfuvirtide; Female; Fetal Blood; Fetus; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Maraviroc; Nevirapine; Organophosphonates; Peptide Fragments; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Tenofovir; Triazoles; Viral Load; Zidovudine | 2011 |
Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.
Topics: Adenine; Administration, Intravaginal; Anti-Infective Agents; Antiviral Agents; Biopharmaceutics; Contraception; Disease Transmission, Infectious; Drug Delivery Systems; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Unplanned; Tenofovir | 2012 |
New advances in chronic hepatitis B.
Topics: Adenine; Antiviral Agents; Coinfection; Disease Progression; Drug Resistance, Viral; Female; Guanine; Guidelines as Topic; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; HIV Infections; Humans; Interferons; Liver Cirrhosis; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Tenofovir | 2012 |
29 trial(s) available for tenofovir and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use.
Topics: Adolescent; Adult; Female; HIV Infections; Humans; Incidence; Infectious Disease Transmission, Vertical; Pre-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Risk Factors; Sexual Behavior; South Africa; Tenofovir; Young Adult | 2021 |
Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus.
Topics: Antiviral Agents; Child, Preschool; Female; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Tenofovir | 2022 |
Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viremia | 2023 |
Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Lopinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Ultrasonography, Prenatal; Young Adult; Zidovudine | 2019 |
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Drug Therapy, Combination; Emtricitabine; Female; Gestational Age; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Oxazines; Piperazines; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyridones; Tenofovir; Ultrasonography, Prenatal | 2021 |
Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Alanine Transaminase; Antiviral Agents; Biomarkers; Cohort Studies; Coinfection; Ethiopia; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult | 2017 |
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult | 2018 |
Tenofovir Disoproxil Fumarate Use during Pregnancy and Infant Bone Health: the Tenofovir in Pregnancy Pilot Study.
Topics: Adult; Anti-HIV Agents; Bone and Bones; Bone Density; China; Coinfection; Female; Hepatitis B; HIV Infections; Humans; Infant; Infant Health; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Young Adult | 2018 |
Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.
Topics: Adult; Antiviral Agents; Bone Density; Double-Blind Method; Female; Gestational Age; Hepatitis B; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult | 2019 |
Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Drug Administration Schedule; Female; Fetal Blood; HIV Infections; Humans; Infant, Newborn; Labor, Obstetric; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Young Adult | 2014 |
High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Cohort Studies; Double-Blind Method; Female; Fertilization; HIV Infections; Humans; Kenya; Medication Adherence; Organophosphonates; Pre-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Regression Analysis; Tenofovir; Uganda; Young Adult | 2014 |
Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.
Topics: Adenine; Adult; DNA, Viral; Female; Follow-Up Studies; Gestational Age; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maternal Age; Multivariate Analysis; Organophosphonates; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Reference Values; Risk Assessment; Taiwan; Tenofovir; Treatment Outcome; Viral Load; Young Adult | 2015 |
Rapid Antiretroviral Therapy Initiation for Women in an HIV-1 Prevention Clinical Trial Experiencing Primary HIV-1 Infection during Pregnancy or Breastfeeding.
Topics: Adult; Africa, Eastern; Anti-HIV Agents; Breast Feeding; Early Medical Intervention; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Post-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Young Adult | 2015 |
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Topics: Adult; Alanine Transaminase; Antiviral Agents; China; Congenital Abnormalities; Creatine Kinase; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Intention to Treat Analysis; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Tenofovir; Viral Load; Young Adult | 2016 |
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus
Topics: Adult; Alanine Transaminase; Antibiotic Prophylaxis; Antiviral Agents; Biomarkers; Double-Blind Method; Female; Gestational Age; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Thailand; Viral Load | 2016 |
Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.
Topics: Antiviral Agents; Biomarkers; Child, Preschool; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Paris; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Tenofovir; Time Factors; Treatment Outcome; Viral Load; Viremia | 2017 |
Breakthrough in the prevention of mother-to-child hepatitis B transmission?
Topics: Adult; Antiviral Agents; Congenital Abnormalities; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Young Adult | 2017 |
Addition of single-dose tenofovir and emtricitabine to intrapartum nevirapine to reduce perinatal HIV transmission.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2008 |
Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).
Topics: Adenine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Maternal-Fetal Exchange; Organophosphonates; Population Groups; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Tenofovir | 2009 |
Intrapartum tenofovir and emtricitabine reduces low-concentration drug resistance selected by single-dose nevirapine for perinatal HIV prevention.
Topics: Adenine; Anti-HIV Agents; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2009 |
Antiretroviral therapies in women after single-dose nevirapine exposure.
Topics: Adenine; Adult; Anti-HIV Agents; Anti-Retroviral Agents; CD4 Lymphocyte Count; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Linear Models; Lopinavir; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Ritonavir; Statistics, Nonparametric; Tenofovir; Treatment Failure; Young Adult | 2010 |
Atazanavir pharmacokinetics with and without tenofovir during pregnancy.
Topics: Adenine; Anti-HIV Agents; Atazanavir Sulfate; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Disease Transmission, Vertical; Oligopeptides; Organophosphonates; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Treatment Outcome | 2011 |
Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2).
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Antiviral Agents; Deoxycytidine; Emtricitabine; Female; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Organophosphonates; Phosphorylation; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir | 2011 |
Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2).
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Female; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2011 |
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants.
Topics: Adenine; Adult; Anti-HIV Agents; Deoxycytidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Young Adult | 2011 |
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Topics: Abortion, Spontaneous; Adenine; Adult; Anti-HIV Agents; Body Height; Body Weight; Breast Feeding; Burns; Cause of Death; Child, Preschool; Congenital Abnormalities; Drug Combinations; Female; Follow-Up Studies; Fractures, Bone; Growth; HIV Infections; HIV Seropositivity; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Measles; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Respiratory Tract Infections; Tenofovir; Uganda; Zidovudine; Zimbabwe | 2012 |
Tenofovir use and renal insufficiency among pregnant and general adult population of HIV-infected, ART-naïve individuals in Lilongwe, Malawi.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Mass Index; CD4 Lymphocyte Count; Creatinine; Cyclopropanes; Drug Combinations; Female; HIV Infections; Humans; Lamivudine; Malawi; Male; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Renal Insufficiency; Tenofovir | 2012 |
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.
Topics: Adenine; Adult; Anti-HIV Agents; Deoxycytidine; Emtricitabine; Europe; Female; Fetal Blood; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Tenofovir; Viral Load; Young Adult | 2013 |
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Oligopeptides; Organophosphonates; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Young Adult | 2013 |
97 other study(ies) available for tenofovir and Complications, Infectious Pregnancy
| Article | Year |
|---|---|
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amniotic Fluid; Anti-HIV Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Fetal Blood; Genitalia, Female; HIV-1; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral | 2009 |
Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Viral Load | 2021 |
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Antiviral Agents; Female; HIV Infections; Humans; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Protease Inhibitors; Tenofovir | 2022 |
Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load.
Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Telbivudine; Tenofovir; Viral Load | 2023 |
Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.
Topics: Antiviral Agents; Cohort Studies; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Viral Load | 2022 |
Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis A; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Tenofovir; Viral Load | 2023 |
[Prevention of Mother-To-Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy].
Topics: Adult; Antiviral Agents; Female; Germany; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Parturition; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2023 |
Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria.
Topics: Adult; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nigeria; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir | 2022 |
Low levels of tenofovir in breast milk support breastfeeding in HBV-infected mothers treated with tenofovir disoproxil fumarate.
Topics: Anti-HIV Agents; Antiviral Agents; Breast Feeding; Female; Hepatitis B virus; Humans; Infant; Infant, Newborn; Milk, Human; Mothers; Placenta; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2023 |
Cost-effectiveness of tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of the hepatitis B virus: real-world analysis from Thailand.
Topics: Antiviral Agents; Cost-Benefit Analysis; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Tenofovir; Thailand; Viral Load | 2023 |
Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
Topics: Child; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Risk Factors; Seroepidemiologic Studies; Tenofovir | 2023 |
Safety of tenofovir during pregnancy: early growth outcomes and hematologic side effects in HIV-exposed uninfected infants.
Topics: Anemia; Anti-HIV Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Growth; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Neutropenia; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Tenofovir; Treatment Outcome | 2020 |
Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Drug Combinations; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Microcephaly; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Puerto Rico; Tenofovir; Young Adult; Zidovudine | 2020 |
Placental infection of hepatitis B virus among Thai pregnant women: Clinical risk factors and its association with fetal infection.
Topics: Adult; Cohort Studies; Female; Fetal Diseases; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Placenta Diseases; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Risk Factors; Tenofovir; Thailand; Viral Load | 2020 |
The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B.
Topics: Antiviral Agents; Cesarean Section; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Tenofovir; Viral Load | 2020 |
Rapid quantification of tenofovir in umbilical cord plasma and amniotic fluid in hepatitis B mono-infected pregnant women during labor by ultra-performance liquid chromatography/tandem mass spectrometry.
Topics: Amniotic Fluid; Animals; Antiviral Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Fetal Blood; Hepatitis B; Humans; Limit of Detection; Pregnancy; Pregnancy Complications, Infectious; Tandem Mass Spectrometry; Tenofovir; Umbilical Cord | 2020 |
Clinical efficacy and safety in telbivudine- or tenofovir-treated hepatitis B e antigen-positive pregnant women.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Treatment Outcome | 2020 |
Tenofovir prophylaxis for preventing mother-to-child hepatitis B virus transmission in China: A cost-effectiveness analysis.
Topics: Antiviral Agents; China; Cohort Studies; Cost-Benefit Analysis; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunization, Passive; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Quality-Adjusted Life Years; Tenofovir; Viral Load | 2020 |
Extent of In Utero Transfer of Tenofovir From Mother to Fetus: A Paired Analysis of Hair Specimens Collected at Birth From a Cohort in the United States.
Topics: Adult; Anti-HIV Agents; Delivery, Obstetric; Female; Fetus; Hair; HIV Infections; Humans; Infant, Newborn; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimesters; Premature Birth; Prospective Studies; Tenofovir; United States; Young Adult | 2021 |
Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study.
Topics: Abnormalities, Drug-Induced; Adenine; Adult; Alanine; Chemoprevention; China; Cohort Studies; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load | 2020 |
Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation.
Topics: Adult; Antiviral Agents; Child; Female; Health Resources; Health Services Accessibility; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Infectious Disease Transmission, Vertical; Male; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Rural Population; Tenofovir; Thailand; Transients and Migrants; Vaccination | 2020 |
Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy.
Topics: Antiviral Agents; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Thailand; Viral Load | 2020 |
Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Drug Interactions; Female; Hepatitis B; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult | 2021 |
Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North America.
Topics: Adult; Antiviral Agents; Cohort Studies; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Male; North America; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Tenofovir | 2020 |
Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study.
Topics: Alanine; Antiviral Agents; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir; Viral Load | 2021 |
Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis.
Topics: Adult; Antiviral Agents; Cost-Benefit Analysis; Female; Hepatitis B; Humans; Infectious Disease Transmission, Vertical; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Reproducibility of Results; Rural Population; Tenofovir; Thailand; Viral Load; Young Adult | 2021 |
Progress towards elimination of mother-to-child transmission of hepatitis B virus infection in China: a modelling analysis.
Topics: Adult; Antiviral Agents; China; Disease Eradication; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2021 |
Factors associated with non-compliance with breastfeeding recommendation: a retrospective survey in hepatitis B virus-infected mothers who had taken Nucleos(t)ide analogs during pregnancy.
Topics: Adult; Antiviral Agents; Breast Feeding; China; Female; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Nucleosides; Patient Compliance; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Telbivudine; Tenofovir | 2021 |
Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus.
Topics: Child; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy Complications, Infectious; Tenofovir | 2017 |
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients.
Topics: Adult; Atazanavir Sulfate; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Leukocytes, Mononuclear; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimesters; Prospective Studies; Ritonavir; RNA, Viral; Tenofovir; Viral Load | 2017 |
Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission.
Topics: Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Tenofovir | 2017 |
Call to Action: Prevention of Mother-to-Child Transmission of Hepatitis B in Africa.
Topics: Africa South of the Sahara; Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; HIV Infections; Humans; Immunization Programs; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load | 2018 |
Preterm delivery and small-for-gestation outcomes in HIV-infected pregnant women on antiretroviral therapy in rural South Africa: Results from a cohort study, 2010-2015.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Retrospective Studies; Rural Population; South Africa; Tenofovir; Young Adult | 2018 |
Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Botswana; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Fetal Death; Gestational Age; HIV Infections; Humans; Infant, Low Birth Weight; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Stillbirth; Tenofovir | 2018 |
Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Disease Transmission, Infectious; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Zidovudine | 2018 |
Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China.
Topics: Adolescent; Adult; Antiviral Agents; China; Cost-Benefit Analysis; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Tenofovir; Viral Load; Young Adult | 2018 |
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2018 |
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2018 |
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2018 |
Tenofovir to Prevent Perinatal Transmission of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2018 |
Monitoring and treatment results of 88 HBsAg-positive pregnant women.
Topics: Adult; Antiviral Agents; Female; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Retrospective Studies; Tenofovir; Young Adult | 2016 |
Prevention of Mother-to-Child Transmission in Patients with Chronic Hepatitis B Virus Infection and High Viral Loads
Topics: Antiviral Agents; Female; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load | 2018 |
Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy.
Topics: Adolescent; Adult; Antiviral Agents; Case-Control Studies; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Telbivudine; Tenofovir; Viral Load; Young Adult | 2019 |
Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
Topics: Alanine Transaminase; Antiviral Agents; Asian People; Black People; Deprescriptions; Disease Progression; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; North America; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Tenofovir; Viral Load | 2019 |
Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
Topics: Adult; Antiviral Agents; Child; Cost-Benefit Analysis; Developing Countries; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Mass Screening; Models, Biological; Pregnancy; Pregnancy Complications, Infectious; South Africa; Tenofovir; Vaccination; Young Adult | 2019 |
Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa.
Topics: Adolescent; Adult; Anti-HIV Agents; Female; Fertilization; Follow-Up Studies; HIV; HIV Infections; Humans; Incidence; Medication Adherence; Pre-Exposure Prophylaxis; Pregnancy; Pregnancy Complications, Infectious; Safe Sex; South Africa; Tenofovir; Young Adult | 2019 |
Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Topics: Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Young Adult | 2019 |
Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.
Topics: Adenine; Adult; Age Factors; Anti-HIV Agents; CD4 Lymphocyte Count; Contraindications; Creatinine; Female; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Kidney Diseases; Male; Mothers; Organophosphonates; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pregnant Women; Prevalence; South Africa; Tenofovir; Viral Load | 2013 |
Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy.
Topics: Adenine; Adolescent; Anti-HIV Agents; Child Development; Female; Humans; Infant; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Weight Gain | 2013 |
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Topics: Adenine; Antiviral Agents; Biomarkers; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunization Schedule; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome; Turkey; Viral Load | 2013 |
Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare.
Topics: Adenine; Adult; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Male; Organophosphonates; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Severity of Illness Index; Tenofovir; Time Factors; Young Adult | 2014 |
Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Chemoprevention; Cohort Studies; Cyclopropanes; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Retrospective Studies; Rural Population; Tenofovir; Young Adult | 2014 |
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; Female; Gastrointestinal Diseases; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Tenofovir; Time Factors; Treatment Outcome; Viral Load | 2014 |
Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
Topics: Adenine; Antiviral Agents; DNA, Viral; Female; Guanine; Health Personnel; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Professional-to-Patient; Infectious Disease Transmission, Vertical; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Viral Load; Viremia | 2014 |
Comparing genotoxic signatures in cord blood cells from neonates exposed in utero to zidovudine or tenofovir.
Topics: Aneuploidy; Anti-HIV Agents; Female; Fetal Blood; Gene Expression; Hematopoietic Stem Cells; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine | 2015 |
Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
Topics: Adenine; Adult; Antiviral Agents; Apgar Score; Biomarkers; Birth Weight; China; DNA, Viral; Drug Resistance, Viral; Drug Substitution; Female; Genotype; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Live Birth; Male; Middle Aged; Mutation; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Vaccination; Viral Load; Young Adult | 2015 |
A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Viral; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Mothers; Mutation; Nevirapine; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; South Africa; Tenofovir; Viral Load; Zidovudine | 2015 |
Pharmacokinetics of tenofovir during pregnancy and postpartum.
Topics: Adolescent; Adult; Anti-HIV Agents; Area Under Curve; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Tenofovir; Young Adult | 2015 |
Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children.
Topics: Adolescent; Adult; Anti-HIV Agents; Bone Density; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maternal Exposure; Meconium; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Young Adult | 2015 |
Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.
Topics: Adult; Anti-HIV Agents; Bone Density; Cross-Sectional Studies; Female; HIV Infections; Humans; Infant, Newborn; Maternal Exposure; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; United States | 2015 |
[Prevention of mother to child transmission of hepatitis B].
Topics: Adult; Antiviral Agents; Female; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Viral Load; Young Adult | 2015 |
Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Canada; Cohort Studies; Female; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir; Treatment Outcome; Viral Load; Viremia | 2016 |
Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
Topics: Adult; Antiviral Agents; Biomarkers; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Treatment Outcome; Viral Load; Virus Replication | 2015 |
Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up.
Topics: Adult; Antiviral Agents; Biomarkers; DNA, Viral; Female; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Tenofovir; Time Factors; Viral Load; Viral Proteins; Young Adult | 2015 |
Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Chromatography, Liquid; Cyclopropanes; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Pregnancy; Pregnancy Complications, Infectious; Tandem Mass Spectrometry; Tenofovir; Viral Load; Young Adult | 2016 |
Growth indices in breastfed infants pre and postnatally exposed to tenofovir compared with tenofovir-unexposed infants.
Topics: Anti-HIV Agents; Breast Feeding; Child Development; Female; HIV Infections; Humans; Infant; Infant, Newborn; Malawi; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2016 |
Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya.
Topics: Adult; Anti-HIV Agents; Antibiotic Prophylaxis; Birth Weight; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Tenofovir; Young Adult | 2015 |
In Utero Tenofovir Exposure Is not Associated With Fetal Long Bone Growth.
Topics: Adult; Anti-HIV Agents; Bone Development; Clinical Trials as Topic; Female; Femur; Fetal Development; Follow-Up Studies; HIV Infections; Humans; Humerus; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2016 |
HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Viral Load; Zidovudine | 2016 |
In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.
Topics: Anti-HIV Agents; Birth Weight; Child Development; Female; Fetal Development; Fetal Growth Retardation; Follow-Up Studies; Growth Disorders; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Tenofovir | 2016 |
Serum Phosphate and Creatinine Levels in the First Year of Life in Infants Born to HIV-Positive Mothers Receiving Tenofovir-Based Combination Regimens During Pregnancy and Prolonged Breastfeeding in an Option B+ Program in Malawi.
Topics: Adult; Anti-HIV Agents; Biomarkers; Breast Feeding; Creatinine; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malawi; Male; Mothers; Phosphates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2016 |
Tenofovir for Prevention of Mother to Child Transmission of Hepatitis B, Evidence based Medicine Viewpoint.
Topics: Antiviral Agents; Child; Evidence-Based Medicine; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy Complications, Infectious; Tenofovir | 2016 |
Tenofovir for Prevention of Mother to Child Transmission of Hepatitis B, Obstetricians Viewpoint.
Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy Complications, Infectious; Tenofovir | 2016 |
Tenofovir for Prevention of Mother to Child Transmission of Hepatitis B,Neonatologists Viewpoint.
Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Mothers; Neonatologists; Pregnancy Complications, Infectious; Tenofovir | 2016 |
Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057.
Topics: Anti-HIV Agents; Bone Density; Brazil; Cohort Studies; Female; HIV Infections; Humans; Infant; Infant, Newborn; Malawi; Maternal Exposure; Pregnancy; Pregnancy Complications, Infectious; Radiography; Spine; Tenofovir; Wrist | 2017 |
Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants.
Topics: Adult; Anthropometry; Anti-HIV Agents; Body Height; Child Development; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Prospective Studies; South Africa; Tenofovir; Young Adult | 2017 |
Antiretrovirals causing severe pre-eclampsia.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Delivery, Obstetric; Female; HIV Infections; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Lamivudine; Nevirapine; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine | 2016 |
Response to 'In-utero exposure to tenofovir is associated with impaired fetal and infant growth' by Denneman et al.
Topics: Anti-HIV Agents; Female; HIV Infections; Humans; Infant; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Tenofovir | 2017 |
In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply.
Topics: Anti-HIV Agents; Follow-Up Studies; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy Complications, Infectious; Tenofovir | 2017 |
Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.
Topics: Adenine; Age Factors; Animals; Anti-HIV Agents; Disease Models, Animal; Female; HIV Infections; HIV-1; Humans; Macaca mulatta; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Time Factors; Treatment Outcome | 2008 |
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.
Topics: Adenine; Anti-HIV Agents; Area Under Curve; Clinical Trials as Topic; Deoxycytidine; Emtricitabine; Female; Half-Life; HIV Infections; HIV-1; Humans; Infant, Newborn; Maternal-Fetal Exchange; Organophosphonates; Population Groups; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Tenofovir | 2009 |
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pyrrolidinones; Raltegravir Potassium; RNA, Viral; Tenofovir; Viral Load; Viremia | 2010 |
Antiretroviral vaginal gel shows promise against HIV.
Topics: Adenine; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Clinical Trials as Topic; Female; Gels; HIV Infections; HIV Seropositivity; Humans; Incidence; Infectious Disease Transmission, Vertical; Medication Adherence; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; South Africa; Tenofovir; Vagina | 2010 |
Implementing a tenofovir-based first-line regimen in rural Lesotho: clinical outcomes and toxicities after two years.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Female; HIV Infections; Humans; Lesotho; Male; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Rural Population; Tenofovir; Treatment Outcome | 2011 |
Battles with donors cloud Malawi's HIV prevention plan.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Charities; Cyclopropanes; Drug Costs; Drug Therapy, Combination; Female; Health Policy; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Lamivudine; Malawi; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2011 |
Microbicide might protect pregnant women from HIV. Susceptibility is high for them.
Topics: Adenine; Disease Susceptibility; Female; HIV Infections; Humans; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Tenofovir | 2011 |
Pregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 women.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Drug Monitoring; Female; HIV Infections; HIV-1; Humans; Middle Aged; Models, Biological; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Reverse Transcriptase Inhibitors; Tenofovir; Young Adult | 2012 |
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.
Topics: Adenine; Anti-HIV Agents; Body Size; Child Development; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Small for Gestational Age; Male; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Tenofovir | 2012 |
Does maternal use of tenofovir during pregnancy affect growth of HIV-exposed uninfected infants?
Topics: Adenine; Anti-HIV Agents; Body Size; Female; HIV Infections; Humans; Infant, Newborn; Male; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2012 |
Research. Fetuses unaffected by tenofovir, 1-year-olds appear slightly smaller.
Topics: Adenine; Female; Fetus; Growth; HIV Infections; Humans; Infant; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Tenofovir | 2012 |
Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
Topics: Adenine; Administration, Oral; Adult; Anti-Retroviral Agents; Centers for Disease Control and Prevention, U.S.; Contraindications; Deoxycytidine; Drug Labeling; Emtricitabine; Female; Heterosexuality; HIV Infections; Homosexuality; Humans; Male; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Risk; Sexual Behavior; Tenofovir; United States | 2012 |
Tenofovir use and pregnancy among women initiating HAART.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Middle Aged; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Prospective Studies; Risk Assessment; South Africa; Tenofovir; Treatment Outcome; Women's Health | 2012 |
Blunted fetal growth by tenofovir in late pregnancy.
Topics: Adenine; Adult; Anti-HIV Agents; Asian People; Bone Density; Female; Fetal Growth Retardation; Hepatitis B; HIV Seropositivity; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2012 |
The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
Topics: Adenine; Antiviral Agents; Drug Approval; Drug Resistance, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Netherlands; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Renal Insufficiency; Telbivudine; Tenofovir; Thymidine | 2012 |
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.
Topics: Adenine; Allied Health Personnel; Antibodies, Viral; Antiviral Agents; Canada; Coinfection; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Interferons; Kidney Diseases; Liver; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2012 |
Congenital pyelectasis in children born from mothers on tenofovir containing therapy during pregnancy: report of two cases.
Topics: Adenine; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Newborn; Italy; Kidney; Male; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2007 |
Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies.
Topics: Adenine; Animals; Animals, Newborn; Antiviral Agents; Biological Transport; Body Weight; Female; Immunophenotyping; Macaca mulatta; Maternal-Fetal Exchange; Organophosphonates; Organophosphorus Compounds; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Simian Acquired Immunodeficiency Syndrome; Tenofovir; Viral Load | 1999 |